MedPath

COVID-19; Comparative Study of Serum S-reactive IgG4 Antibody Levels, N-reactive IgG Antibody Levels, and S-reactive IgG Antibody Levels in COVID-19 mRNA Vaccine Recipients and Non-Recipients using IgG Antibody Testing

Recruiting
Conditions
none
Registration Number
jRCT1030250071
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
180
Inclusion Criteria

Japanese people (non-naturalized Japanese nationals) who meet the following requirements. We are looking for 20 people each who have not received the mRNA vaccine and who have received 1 to 8 doses of the mRNA vaccine.

  1. Those who have not received the mRNA vaccine: 20 people
  2. Those who have received 1 dose of the mRNA vaccine: 20 people
  3. Those who have received 2 doses of the mRNA vaccine: 20 people
  4. Those who have received 3 doses of the mRNA vaccine: 20 people
  5. Those who have received 4 doses of the mRNA vaccine: 20 people
  6. Those who have received 5 doses of the mRNA vaccine: 20 people
  7. Those who have received 6 doses of the mRNA vaccine: 20 people
  8. Those who have received 7 doses of the mRNA vaccine: 20 people
  9. Those who have received 8 doses of the mRNA vaccine: 20 people
Exclusion Criteria
  1. Non-Japanese.
  2. Patients currently participating in other clinical trials, or patients who have participated in a clinical trial in the past and for whom more than one month has not passed since the last dose of the test drug.
  3. Patients who are unable to register for this study via online medical consultation or online electronic device, or who are unable to enter data or send it via the Internet, either by themselves or their legal representative.
  4. Patients who the principal investigator or co-investigator of the study deems inappropriate as subjects.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
S-reactive IgG4 antibody

amount of S-reactive IgG4 antibody in blood

N-reactive IgG antibody

amount of N-reactive IgG antibody in blood

S-reactive IgG antibody

amount of S-reactive IgG antibody in blood

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.